Literature DB >> 29706602

Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand.

Passara Jongkhajornpong1, Kaevalin Lekhanont1, Phattrawan Pisuchpen2, Patchima Chantaren2, Vilavun Puangsricharern2, Pinnita Prabhasawat3, Kanya Suphapeetiporn4, Shigeru Kinoshita5, Mayumi Ueta6.   

Abstract

BACKGROUND: Polymorphisms in human leucocyte antigen (HLA) class I genes have been found to be associated with cold medicine (CM)-related Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) with severe ocular complications (SOC). Because ethnic differences in genetic predisposition to SJS/TEN among different populations have been proposed, we focused on Thai patients and investigated the association between HLA class I genotypes and CM-SJS/TEN with SOC.
METHODS: This multicentre case-control study was conducted between September 2014 and August 2017. Seventy-one Thai patients with SJS/TEN with SOC and 159 healthy Thai controls were enrolled. HLA typing was performed. Genetic relationships were analysed using Fisher's exact test.
RESULTS: Of 71 patients with SJS/TEN with SOC (28 male, 43 female), 49 (69%) had a history of taking cold medications prior to SJS/TEN onset. The mean age of onset was 26.7±17.1 years (range, 2-77 years). HLA-B*44:03 (OR, 7.2, p=5.5×10-6, pc=1.1×10-4) and HLA-C*07:01 (OR, 6.1, p=7.1×10-6, pc=1.1×10-4) showed significant positive associations with Thai patients with CM-SJS/TEN with SOC. Additionally, 17 of 49 patients with CM-SJS/TEN with SOC (34.7%) significantly harboured the HLA-B*44:03 and HLA-C*07:01 haplotype compared with only 11 of 159 healthy controls (6.9%) (OR=7.1, p=5.5×10-6).
CONCLUSIONS: HLA-B*44:03-HLA-C*07:01 haplotype is a potential risk factor for CM-SJS/TEN with SOC in the Thai population. This study supports that HLA-B*44:03 might be a common marker for CM-SJS/TEN with SOC in Eurasia populations, including European, Indian, Japanese and Thai. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Stevens-Johnson syndrome; cold medicine; human leucocyte antigen; severe ocular complications

Mesh:

Substances:

Year:  2018        PMID: 29706602     DOI: 10.1136/bjophthalmol-2017-311823

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.

Authors:  David Hui-Kang Ma; Tsung-Ying Tsai; Li-Yen Pan; Shin-Yi Chen; Ching-Hsi Hsiao; Lung-Kun Yeh; Hsin-Yuan Tan; Chun-Wei Lu; Chun-Bing Chen; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-05-12

2.  HLA genotypes and cold medicine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis.

Authors:  Wimonchat Tangamornsuksan; Sirikan Chanprasert; Phenphechaya Nadee; Saowalak Rungruang; Natnaree Meesilsat; Mayumi Ueta; Manupat Lohitnavy
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

3.  Association of IKZF1 SNPs in cold medicine-related Stevens-Johnson syndrome in Thailand.

Authors:  Patchima Chantaren; Passara Jongkhajornpong; Mayumi Ueta; Vilavun Puangsricharern; Kaevalin Lekhanont; Phattrawan Pisuchpen; Pinnita Prabhasawat; Kanya Suphapeetiporn; Shigeru Kinoshita
Journal:  Clin Transl Allergy       Date:  2019-11-22       Impact factor: 5.871

4.  Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.

Authors:  Ken Nakatani; Mayumi Ueta; Seik-Soon Khor; Yuki Hitomi; Yuko Okudaira; Anri Masuya; Yuki Wada; Chie Sotozono; Shigeru Kinoshita; Hidetoshi Inoko; Katsushi Tokunaga
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 5.  Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention.

Authors:  Swapna S Shanbhag; Madhuri A Koduri; Chitra Kannabiran; Pragnya R Donthineni; Vivek Singh; Sayan Basu
Journal:  Front Genet       Date:  2021-01-12       Impact factor: 4.599

Review 6.  Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Eri Tsukagoshi; Yoichi Tanaka; Yoshiro Saito
Journal:  Front Med (Lausanne)       Date:  2021-03-24

7.  Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Rawiphan Panpruk; Vilavun Puangsricharern; Jettanong Klaewsongkram; Pawinee Rerknimitr; Thanachaporn Kittipibul; Yuda Chongpison; Supranee Buranapraditkun
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

Review 8.  Genetics of Severe Cutaneous Adverse Reactions.

Authors:  Shang-Chen Yang; Chun-Bing Chen; Mao-Ying Lin; Zhi-Yang Zhang; Xiao-Yan Jia; Ming Huang; Ya-Fen Zou; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-07-15

9.  Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals.

Authors:  Mayumi Ueta; Ryosuke Nakamura; Yoshiro Saito; Katsushi Tokunaga; Chie Sotozono; Toshio Yabe; Michiko Aihara; Kayoko Matsunaga; Shigeru Kinoshita
Journal:  Hum Genome Var       Date:  2019-10-28

Review 10.  HLA-associated adverse drug reactions - scoping review.

Authors:  Chiara Jeiziner; Ursina Wernli; Katja Suter; Kurt E Hersberger; Henriette E Meyer Zu Schwabedissen
Journal:  Clin Transl Sci       Date:  2021-06-09       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.